Form 4: Elanco CEO Sells Shares for Tax Obligations

Elanco Animal Health Inc.'s CEO, Jeffrey N. Simmons, disposed of 37,898 shares of common stock to cover tax liabilities at a price of $24.88 per share.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), reported a transaction.
• On March 3, 2026, Simmons disposed of 37,898 shares of Elanco Common Stock.
• The disposition was executed at a price of $24.88 per share.
• This transaction was coded as 'F', indicating payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise, or vesting of a security.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following this transaction, Simmons directly beneficially owns 2,051,898 shares of Common Stock.
• Additionally, Simmons indirectly beneficially owns 167,000 shares of Common Stock through a Revocable Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a non-discretionary sale for tax purposes, which is a routine part of executive compensation and does not reflect a change in the company's fundamentals or the executive's long-term outlook.

Positives

• The transaction was a non-discretionary disposition for tax liability, which is a routine event for executives receiving equity compensation and does not indicate a lack of confidence in the company.

Negatives

• No direct negatives for the company are indicated by this routine tax-related transaction.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that dispositions of shares by executives to cover tax liabilities, especially when executed under a Rule 10b5-1 plan, are common occurrences in the animal health industry and across publicly traded companies. These transactions are typically non-discretionary and are part of managing equity compensation.

Stakeholder Impact

• Shareholders: The transaction provides transparency regarding executive stock ownership changes, but as a tax-related disposition, it is unlikely to significantly impact shareholder sentiment or the company's valuation.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

The filing details a routine, non-discretionary sale of shares by the CEO to cover tax liabilities, which is a common practice for executives receiving equity compensation. This type of transaction does not typically signal a change in the company's fundamental prospects or the executive's confidence, thus it does not warrant a change in investment recommendation based solely on this disclosure.

Keywords

Elanco, ELAN, Form 4, Insider Transaction, Jeffrey N. Simmons, CEO, Stock Sale, Tax Liability, Rule 10b5-1